Prognostic relevance of nutritional status in patients with advanced esophageal cancer

By Bollschweiler Elfriede   Herbold Till   Plum Patrick   Hölscher Arnulf H  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 275-278

Informa Healthcare

Access to resources Recommend Favorite

The timing of hormone therapy for men with asymptomatic advanced prostate cancer

By Messing E.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 245-254

Elsevier

Access to resources Recommend Favorite

Treatment decision-making by men with localized prostate cancer: the influence of personal factors

By Berry D.L.   Ellis W.J.   Woods N.F.   Schwien C.   Mullen K.H.   Yang C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 93-100

Elsevier

Access to resources Recommend Favorite

Nutritional Status Is Superior to the ECOG Performance Status in Predicting the Dose-Intensity of the GEMOX Chemotherapy Regimen in Patients with Advanced Cancer

By Cessot Anatole   Coriat Romain   Mir Oliver   Boudou-Rouquette Pascaline   Giroux Julie   Durand Jean-Philippe   Alexandre Jérôme   Goldwasser Francois  

Nutrition and Cancer, Vol. 65, Iss. 8, 2013-11 ,pp. : 1254-1257

Routledge Ltd

Access to resources Recommend Favorite

Factors influencing primary care physicians’ decision to order prostate-specific antigen (PSA) test for men without prostate cancer

By Hayat Roshanai Afsaneh   Nordin Karin   Berglund Gunilla  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1602-1608

Informa Healthcare

Access to resources Recommend Favorite